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1. Summary
For the catalytic mechanism of proton-translocat-
 .ing NADH-dehydrogenase complex I, EC 1.6.99.3
a number of hypothetical models have been proposed
over the last three decades. These models are dis-
cussed in the light of recent substantial progress on
the structure and function of this very complicated
multiprotein complex.
Only the high-potential iron-sulfur center N-2 and
ubiquinone seem to contribute to the proton-trans-
locating machinery of complex I: Based on the pH
dependent midpoint potential of iron-sulfur cluster
N-2 and the physical properties of ubiquinone inter-
mediates a novel mechanism is proposed. The model
builds on a series of defined chemical reactions tak-
ing place at three different ubiquinone-binding sites.
Therefore, some aspects of this redox-gated ligand
conduction mechanism are reminiscent to the proton-
motive Q-cycle. However, its central feature is the
abstraction of a proton from ubihydroquinone by a
redox-Bohr group associated with iron-sulfur cluster
N-2. Thus, in the proposed mechanism proton
translocation is driven by a direct linkage between
redox dependent protonation of iron-sulfur cluster
N-2 and the redox chemistry of ubiquinone.
2. Introduction
The proton-translocating NADH-dehydrogenase
 .complex I, EC 1.6.99.3 is by far the most compli-
cated and least understood multisubunit enzyme of
the respiratory chain in mitochondria and aerobic
w xbacteria 1–3 . The oxidation of one NADH by this
integral membrane-protein is considered to be linked
q y w x w xto the translocation of 4 H r2 e 4–6 , see 7 for
.a more detailed discussion of this issue across the
energy transducing membrane. The electrons are
transferred onto the hydrophobic hydrogen-carrier
ubiquinone. Substantial progress has been made dur-
ing recent years in defining the overall structural
w xorganization 8 , in determining the subunit structure
w xof eucaryotic 3,9,10 and procaryotic complexes
w x9,11 and in characterizing the numerous iron-sulfur
w xclusters of complex I 12 . However, little is known
about the mechanisms linking electron transfer to
vectorial proton-translocation in complex I. Several
more or less detailed hypothetical models for proton-
translocation have been proposed, which cover a
wide range of options.
The purpose of this review is to give an overview
over the mechanistic models that have been proposed.
The available evidence is summarized to define the
structural and thermodynamic constraints the proton-
translocating device in complex I has to meet. Possi-
ble analogies to other proton-translocating enzymes
are explored. This discussion then leads to the pro-
posal of a detailed and thermodynamically feasible
model which should be useful to clarify some general
principles involved and guide further experimental
work.
3. Structural organization, redox groups and
ubiquinone binding sites
Mammalian complex I consists of at least 42
w xdifferent subunits 2 and even bacterial complexes
w xcontain 14 subunits 9,11 . Complex I contains one
FMN as a prosthetic group and 6 iron-sulfur centers
w xhave been identified by EPR spectroscopy 12,13
 .Table 1 . An L-shaped overall structure was deduced
from electron microscopic analysis of the Neu-
˚ w xrospora crassa enzyme at about 8 A resolution 14 .
Different lines of evidence indicate that this L-shaped
multiprotein structure can be divided into several
w xsubcomplexes 15,16 , which are likely to have devel-
w xoped from different evolutionary origins 17 . This
issue has been the subject of several recent reviews
w x2,10,18–20 . Therefore, only aspects of immediate
relevance to the localization and function of the
Table 1
Midpoint potentials of the iron-sulfur centers of bovine heart
complex I
 .Iron-sulfur Type E mV pH-dependencem7
center
N-1a Fe S y370 q2 2
N-1b Fe S y250 y2 2
N-2 Fe S y150 q2 2
N-3 Fe S y250 y4 4
N-4 Fe S y250 y4 4
N-5 Fe S y260 y4 4
w xAssignments and E values are taken from 30 .m7
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Fig. 1. Diagram of the overall shape and approximate position of
the redox-centers and substrate binding sites of complex I. The
˚overall shape was adapted from an reconstruction at about 8 A
resolution using data from electron microscopic analysis of N.
w xcrassa complex I 14 . The reactions catalyzed by this membrane
bound NADH-dehydrogenase are also indicated, namely the oxi-
dation of NADH, the reduction of ubiquinone and a translocation
of 4 protons linked to this redox reaction. The white area
tentatively indicates the peripheral arm of the enzyme, which
should correspond roughly to the Il subcomplex of the bovine
w xenzyme 21 . The placement of the NADH-substrate binding site,
FMN and the six iron-sulfur centers in this part of the enzyme are
arbitrary, as no information is available on their exact positions.
Only for iron-sulfur cluster N-2 there is evidence that it resides
w xclose to the membrane part 21,30 . The grey area indicates the
membrane part of the enzyme which carries the binding sites for
w xubiquinone and two EPR-detectable semiquinone species 29 .
Again the position of the substrate binding site and the
semiquinones are given arbitrarily, with the exception that one of
˚the semiquinones has been reported to be 8–11 A apart from
w x Pyiron-sulfur cluster N-2 29 . Q, ubiquinone; Q , ubisemiquinone;
QH , ubihydroquinone; N-1a, N-1b, N-2,N-3,N-4,N-5, EPR-de-2
w xtectable iron-sulfur clusters of complex I 30 .
proton-translocating machinery of complex I will be
discussed here.
Complex I is composed of two major parts Fig.
.1 , which in the N. crassa enzyme have been called
w xthe membrane arm and the peripheral arm 10 . The
peripheral arm seems to correspond roughly to sub-
w xcomplex I l of the bovine enzyme 21 . Both contain
no mitochondrially coded, hydrophobic subunits and
comprise two smaller subcomplexes that have been
w xknown for a long time 15,22,23 , the so called
 .flavoprotein FP and the so called iron-sulfur protein
 .IP . However, while bovine subcomplex I l con-
tains all known prosthetic groups, namely FMN and
w xall EPR detectable iron-sulfur clusters 21 , iron-sulfur
cluster N-2 was not found in the peripheral arm of
w xthe N. crassa enzyme 10 . Remarkably, compared to
the intact enzyme, the EPR spectrum of iron-sulfur
w xcluster N-2 was broadened in subcomplex I l 21 .
As subcomplex I l is also not capable of transferring
w xelectrons onto ubiquinone 21 , it can be concluded
that the membrane arm contains no known prosthetic
group, but has to be the part of the enzyme which
carries the ubiquinone binding sites. The above men-
tioned biochemical evidence and the fact that iron-
sulfur cluster N-2 titrates at a much higher midpoint
potential than all other iron-sulfur clusters of com-
 .plex I Table 1 further suggests that this redox group
is located at the interface between the two major
parts of the enzyme catalyzing electron transfer from
w xthe peripheral part onto the membrane part 21,24,25 .
Based on kinetic studies using specific inhibitors
w xof complex I like rotenone and piericidin A 26 and
ubiquinone derivatives with varying hydrophobicity
w x27,28 it has been suggested that there are at least
two ubiquinone reactive sites within the membrane
domain of complex I. This notion has received fur-
ther support from the recent observation of two
ro tenone-sensitive and energy-dependent
semiquinones by EPR-spectroscopy with tightly-cou-
w xpled submitochondrial particles oxidizing NADH 29 .
Taking advantage of the spin-spin interaction be-
 .tween one of the semiquinones SQ with iron-Nf
˚sulfur cluster N-2 a distance of 8–11 A between the
w xtwo paramagnetic species has been estimated 29 .
This fits well with the idea of iron-sulfur cluster N-2
being the electron donor to ubiquinone, but it seems
to make it even more difficult to understand how a
second or even a third ubiquinone could participate in
electron transfer and possibly proton-translocation.
This is true in particular, if one considers the appar-
ent absence of redox groups in the membrane part of
complex I.
At present for none of the redox-centers or sub-
strate binding sites of complex I the exact positions
within the overall structure and relative to the mem-
brane are known. However, the bipartite structure of
a water soluble peripheral part that contains all known
prosthetic groups and a membrane part that carries
 .the binding sites for ubiquinone Fig. 1 provides a
framework that imposes important constraints onto
the proton-translocating machinery.
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4. Synopsis of proposed mechanisms
w xThe presence of at least 6 iron-sulfur clusters 30 ,
one FMN and at least two quinone binding sites in
principle allows a remarkable number of permuta-
tions for the sequence of electron and proton-trans-
fers within complex I. Over the last three decades
many of these options have been incorporated into a
number of quite different mechanistic models. A
comparison of these models seems worthwhile, as
this should provide a useful basis for the incorpora-
tion of current knowledge about the functional prop-
erties of complex I and the actual arrangement of its
redox-centers and binding sites.
Fig. 2 gives an overview over 8 representative
mechanistic models that have been proposed over the
years. The purpose of this synopsis is to stress the
fundamental similarities and differences using a con-
sistent set of symbols rather than to reproduce every
detail of each model for which the reader should refer
to the respective original publications.
w xPeter Mitchell’s original proposal 31 for a redox
 .loop at ‘coupling site I’ Fig. 2A did not take into
account even the existence of a multiprotein complex
conferring this activity. However, already this model
pinpointed the hydrogen carrier FMN as potential
proton-translocator and the iron-sulfur clusters as
electron wires. After ‘coupling site I’ had been iden-
w xtified as NADH-ubiquinone oxidoreductase 32 ,
w xLawford and Garland 33 modified the loop as shown
in Fig. 2B.
When a rotenone sensitive semiquinone radical
w xwas detected by EPR spectroscopy 34 the idea that
a bound QrQHP couple could be involved in proton-
w xtranslocation 35 became more attractive. Stimulated
by the protonmotive Q-cycle that had been proposed
w xfor the cytochrome bc complex 36 this concept led1
w xSuzuki and King 34 to formulate a Q-cycle type
 .mechanism for complex I Fig. 2C . This proposal
essentially just changes the proton carrier from FMN
to ubiquinone and, different from the Q-cycle operat-
ing in the cytochrome bc complex, does not increase1
the Hqr2ey stoichiometry above 2. However, it was
shown later that this stoichiometry is higher for the
w xcomplex I segment 4–6 and is now considered to be
q y w x4 H r2e by most authors 7,37,38 . The experimen-
w xFig. 2. Synopsis of eight representative proposals for redox-linked proton-translocation by complex I. A, Mitchell, 1966 31 ; B, Lawford
w x w x w x w xand Garland, 1972 33 ; C, Suzuki and King, 1983 34 ; D, Krishnamoorthy and Hinkle, 1988 40 ; E, Ragan, 1990 45 ; F, Weiss et al.,
w x w x w x1991 7,14,46 ; G, Vinogradov, 1993 25,47 ; H, Degli Esposti and Ghelli, 1994 39 . See text for details. Straight arrows indicate electron
transfer reactions, dotted arrows hydrogen transfer. Curved arrows show substrate exchange. Bold gray arrows are used to show proton
uptake or release. Bound electron carriers are boxed and bound hydrogen carriers are shown on gray background. FeS, iron-sulfur
 . Py Pcenter s ; N-2, iron-sulfur center N-2; Q, ubiquinone; Q , QH ubisemiquinone; QH , ubihydroquinone.2
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tal evidence for this value as the mechanistic stoi-
chiometry of complex I is rather solid. The lower
w xstoichiometries observed under some conditions 5,39
could be due to ‘slip’ of the protonmotive mecha-
nism.
Krishnamoorthy and Hinkle went back to the idea
that the key component for proton-translocation was
w xthe flavin 40 . Their proposal accounts for a higher
proton-translocation stoichiometry by assuming that
the FMN changes only between the deprotonated
semiquinone and the fully protonated reduced form,
with protonations occurring towards the negative and
deprotonations towards the positive side of the mem-
brane. In the variant of their mechanism shown in
Fig. 2D electrons instead of hydrogens are transferred
from NADH to FMN via iron-sulfur centers which
results in the release of substrate protons on the
negative side of the membrane. The electrons are
transferred via iron-sulfur cluster N-2 onto ubiquinone
where substrate protons are taken up. In this model
cluster N-2 was proposed to lie behind the proton-
translocating machinery as its midpoint potential was
taken as y30 mV, but is now considered to have an
E of y150 mV in bovine heart complex I cf.m7
.Table 1 . Aside from this discrepancy this intrigu-
ingly simple model is likely to be incorrect for other
reasons of general significance: This mechanism re-
quires that the flavin-semiquinone becomes fully ion-
ized and the reduced flavin fully protonated during
each catalytic cycle. As stated by the authors them-
w xselves 40 , taking the pK values of 8.5 for freea
FMNHP and 6.5 for free FMNH a priori such a2
protonationrdeprotonation behavior is not expected.
However shifting the effective pK values of onea
and the same redox group into opposite directions
depending on its redox state is not a trivial task and
requires a specific mechanism promoting it. In fact,
recently pK values of 7.7 for the semiquinone forma
and 7.1 for the reduced form of FMN bound to
w xcomplex I have been reported 41 . A good example
of what is necessary to operate a mechanism based
on redox-linked protonationrdeprotonation is the his-
w xtidine-cycle 42,43 which has been proposed by
Wikstrom as the proton-translocating rationale for¨
cytochrome c oxidase. Another problem arises from
the postulate that a single electron redox change
would force the uptake or release of two protons, as
this leaves one charge uncompensated. However,
charge compensation is of central importance for a
proton-translocating machinery, as has been worked
w xout by Rich also for cytochrome c oxidase 44 .
 w x.The proposal by Ragan Fig. 2E, 45 includes the
possibility of branching the electron path at the level
of flavine and ubiquinone and cycling it back via
iron-sulfur clusters. Variations of this scheme can
account for Hqr2ey stoichiometries between 2 and
6. Its major setback is that it offers many possible
variations without specifying the actual reaction se-
quences during normal turnover. Also at last some
variants of the scheme seem to be difficult to recon-
cile with thermodynamics for similar reasons as dis-
cussed in the previous paragraph.
Participation of the two hydrogen carriers involved
was put together in a more straightforward way by
w xWeiss and coworkers 7,14,46 . According to this
proposal 2 Hqr2ey are transported across the mem-
brane by each, the FMNrFNNH couple and an2
 .‘internal’ QrQH couple Fig. 2F . Although this2
circumvents some of the thermodynamic inconsisten-
cies of other models and gives an overall stoichiom-
etry of 4 Hqr2ey, no explanation is given how the
internal ubihydroquinone can be reoxidized by iron-
sulfur cluster N-2. However, this is not a trivial
question considering a midpoint potential of this re-
dox-center below y100 mV. Also the problem of
promoting a cyclic reduction and reoxidation of the
 .rather positive QrQH couple E sq70 mV in2 m7
the absence of any high-potential redox site is not
addressed by this proposal.
A similar scheme was proposed by Vinogradov
w x q y25,47 which accounts for a H r2e stoichiometry
 .of 3 Fig. 2G , while based on the available reports
w xon proton stoichiometries 4–6 now a value of 4
Hqr2ey is considered most likely. The reason for
the lower value is that this model, like the ‘Q-cycle’
 .variant of Krishnamoorthy and Hinkle Fig. 2C ,
employs QrQHP couples rather than a QrQH cou-2
ple. However, Vinogradov’s mechanism addresses
two important aspects. Firstly, postulating one ‘trans-
locating’ and one ‘substrate’ ubiquinonersemi-
quinone couple which symproportionate to give the
product ubihydroquinone implies a thermodynami-
cally feasible reaction sequence capable of translocat-
ing 1 Hqr2ey against the membrane potential. The
only points remaining unclear are how the ‘trans-
locating’ semiquinone gets moved across the mem-
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brane or how it is ascertained that protonation and
deprotonation occur at opposite sides of the mem-
brane. As discussed earlier for the FMN- dependent
mechanism by Krishnamoorthy and Hinkle cf. Fig.
.2D this and the question of effective pK values fora
the intermediates involved is a central question for
any directional protonationrdeprotonation mecha-
nism. The second important aspect discussed by
w xVinogradov 25 is the role of cluster N-2. According
to his model, electron transfer from this redox center
onto ubiquinone has to be ‘blocked’ at certain stages
of the catalytic cycle to prevent it from reducing
semiquinone to hydroquinone. However, no clues are
given how such a conditional electron transfer could
be controlled. Nevertheless, as cluster N-2 has been
˚found to be only 8–11 A apart from one of the
w xEPR-detectable ubisemiquinones 29 and thus seems
to be the immediate reductant of ubiquinone, it is in
fact a likely candidate for the control of a putative
ubiquinone-dependent proton-translocating process
 .see below .
The dual Q-gated pump model by Degli Esposti
w xand Ghelli 39 entirely abandons any contributions to
the proton-translocation process by the electron input
part of complex I containing FMN and the iron-sulfur
clusters. As shown in Fig. 2H, translocation of 4
Hqr2ey is proposed to be linked to the sequential
formation of two types of semiquinones. After two
semiquinones have formed in the second site, they
are supposed to dismutate resulting in the net forma-
tion of one ubihydroquinone. It remains unclear how-
ever, how such a ‘gated pump’ would work in detail.
If the translocation process was directly linked to the
protonationrdeprotonation of the ubisemiquinones
involved, the same difficulties as for Vinogradov’s
mechanism would apply. Indirect ‘pump’-mecha-
nisms, on the other hand, are difficult to prove or
disprove and seem unlikely in the light of better
understood mechanisms operating in other proton-
w xtranslocating enzymes 43,48,49 . Apart from these
more general points, there are two more specific
problems associated with the dual Q-gated pump
 .which seem to exclude this mechanism: i if two
semiquinone anions have to exist in the same
ubiquinone-binding pocket at some point during the
catalytic cycle to allow dismutation, formation of the
second semiquinone is expected to be highly ender-
 .gonic for electrostatic reasons; ii if the immediate
donor to the bound quinone is iron-sulfur cluster N-2
with an E fy150 mV, only about half of them7
potential drop between NADqrNADH and the
QrQH couple is available to drive vectorial proton-2
transport of 4 Hqr2ey. In fact, this is one of the key
problems for any mechanism based on ubiquinone as
hydrogen carrier which does not employ FMN and
the iron-sulfur clusters for proton-translocation.
In recent years Dutton and Ohnishi have empha-
sized as well that proton translocation of complex I is
likely to employ a variation of the protonmotive
Q-cycle and employs only ubiquinone as hydrogen
carrier L.P. Dutton and T. Ohnishi, personal commu-
.nication . A mechanistic model based on these ideas
w xhas been presented recently 50 . This model com-
bines a direct reversal of a Q-cycle type mechanism
with a semiquinone-gated proton translocator which
employs the movement of a bound quinone between
two sites and in this respect is somewhat reminiscent
w xto Vinogradov’s proposal 47 .
5. Localization of the proton-translocating ma-
chinery
The most controversial and important question
emerging from the comparison of available models
given in the previous chapter is, whether both hydro-
gen carriers FMN and ubiquinone contribute to pro-
ton-translocation. There is sufficient evidence to con-
clude that at least part of the proton-translocating
machinery is associated with the reactions of
ubiquinone. Most notably, two EPR detectable and
w xrotenone sensitive ubisemiquinone species 29 , the
selective reactivity with ubiquinones of varying hy-
w xdrophobicity 27,28 and kinetic evidence for at least
two types of binding sites for hydrophobic inhibitors
w x26 indicate that complex I carries a minimum of
two ubiquinone reactive sites. Also the assignment of
these sites to the membrane part of the enzyme
supports the notion that ubiquinone contributes to
proton-translocation.
For FMN the situation is much less clear. Different
arguments have been used in favor of a role for FMN
as a proton-translocator. For example, a translocation
of the flavin from one site to another has been
suggested based on the observation that NADH re-
duction of the flavoprotein-subcomplex results in dis-
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w xsociation of FMNH 51 . However, FMN resides in2
the peripheral part of complex I, which can be sepa-
rated as a water-soluble subcomplex. Therefore, if the
redox change of FMN is linked to proton-transloca-
tion there has to be a rather long proton channel
connecting it to the positive side of the membrane.
This situation would be different from other known
proton-translocating enzymes, where the proton-trans-
locating group and the proton channels are found on
w xthe same membrane spanning subunit 52,53 . More-
over, oxidation of NADH by ferricyanide in submito-
chondrial particles was not found to be linked to
w xvectorial proton-transport 39,54 , although this reac-
tion has been reported to occur via oxidoreduction of
w xFMN and at least one iron-sulfur cluster 55 . Thus,
there seems to be no compelling evidence for FMN
being part of the proton-translocating machinery, but
several arguments against this possibility.
On the other hand, as the peripheral part of com-
plex I also contains all iron-sulfur centers including
the ‘high-potential’ cluster N-2 with an E of y150m7
mV, the remaining potential gap appears not to be
sufficient to transport 4 Hqr2ey. The only obvious
way to resolve this dilemma is to postulate that
iron-sulfur cluster N-2 is an active part of the
proton-translocating machinery. In principle, this
could be envisioned in two different ways: cluster
N-2 either is involved in a direct proton-translocating
mechanism somewhat comparable to the histidine-
w xcycle proposed for cytochrome c oxidase 43 , or its
redox-change is linked to a ubiquinone dependent
mechanism. To explore these options, it seems neces-
sary to take a closer look at the properties of iron-
sulfur cluster N-2.
6. Role of iron-sulfur cluster N-2
A correlation between the presence of specific
iron-sulfur clusters and piericidin A sensitive NADH
w xoxidation was first reported a long time ago 56 .
Since then a number of authors have discussed a
possible involvement of the redox-Bohr properties of
w xcluster N-2 in proton-translocation 13,30,57,58 , but
surprisingly redox-linked protonationrdeprotonation
of this center has not been incorporated into any of
the working models for proton-translocation by com-
 .plex I see above .
Fig. 3. Protonation- and redox-states of iron-sulfur cluster N-2 of
bovine heart complex I. The limits for the pK and E valuesa m
w xwere estimated from experimental data given in 13 . N-2, iron-
sulfur cluster N-2; ox, oxidized; red, reduced. Thicker arrows
indicate the direction the reactions take according to the redox-
gated ligand conduction hypothesis.
In bovine heart the midpoint potential of iron-sulfur
cluster N-2 is pH dependent following a slope of
y60 mVrpH unit over a pH-range from 6 to 8.5
w x13 . This means that the pK -value for the oxidizeda
species must be below 6 and that for the reduced
species above 8.5. In turn, this shift of pK by morea
than 2.5 units reflects a difference in midpoint poten-
tial between the deprotonated and the protonated
 .species of at least 150 mV Fig. 3 . In other words,
the midpoint potential of deprotonated cluster N-2 is
in the same range as, or even lower than that of the
other iron-sulfur centers of bovine complex I, except
 .cluster N-1a cf. Table 1 . As another consequence,
cluster N-2 in its reduced state should have a ten-
dency to pick up a proton due to its rather high pK .a
Likewise, the oxidized species should be quite acidic
and deprotonate upon formation. Thus, it can be
concluded that there is a redox-Bohr group associated
with iron-sulfur cluster N-2 which has properties
making it suitable to be a part of the proton-trans-
locating device. Note that if in fact every redox-
change of cluster N-2 is associated with a protona-
tion-change of this group, one of the other iron-sulfur
centers would have to reduce the deprotonated, low
potential species. This means that there would be
practically no potential drop during catalysis, but
abstraction of a proton from somewhere else would
then shift the cluster N-2 midpoint potential to the
positive.
If the redox-Bohr group associated with iron-sulfur
center N-2 is an intrinsic part of the proton-trans-
locating machinery of complex I, it should be present
in all proton-translocating NADH-dehydrogenases.
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Aside for bovine heart complex I, a pH-dependent
midpoint potential of iron-sulfur cluster N-2 has been
w xfound in Escherichia coli 9 , Rhodobacter
w x w xsphaeroides 59 and Paracoccus denitrificans 60 .
A pK of 7.7 for the reduced cluster N-2 has beena
reported for P. denitrificans and the pK of thea
w xoxidized species must be below 6 60 . This corre-
sponds to a redox-dependent pK shift by at leasta
two units. For Thermus thermophilus the situation is
less clear, as no high-potential iron-sulfur cluster has
w xbeen found 61 . The tetranuclear iron-sulfur cluster
which has been proposed to correspond to mam-
malian cluster N-2 exhibits no pH dependence of its
midpoint potential, but seems to form two species
w xwith different midpoint potential above pH 8 61 .
Also, vectorial proton-translocation by complex I
from Th. thermophilus has yet to be demonstrated.
Moreover, this enzyme is a NADH-menaquinone ox-
idoreductase. Menaquinone, however, has a much
lower midpoint potential than ubiquinone and a pro-
ton-translocating machinery, if it exists, would have
to meet different thermodynamic requirements, than
in complex I of other species.
To assess a possible role of cluster N-2 in proton-
translocation, it would also be important to know to
which subunit it is bound and where this subunit is
located relative to the membrane. At present these
questions cannot be answered completely. Two sub-
units have been discussed to carry iron-sulfur cluster
w x  .N-2 19,38,62 namely TYKY 20.2 kDa and PSST
 .20.1 kDa of the bovine enzyme. Homologues of
both subunits are also found in bacterial complex I
w x9,11 .
Subunit TYKY carries eight conserved cysteines
arranged in the consensus pattern CxxCxxCxxxCP-
 . .x -CxxCxxCxxxCP found in bacterial eight-ironn
ferredoxins. This suggests two tetranuclear clusters in
a similar arrangement as in these ferredoxins. The
edge-to-edge distance between the two clusters in
˚Peptococcus aerogenes ferredoxin is less than 6 A
w x63,64 , resulting in strong electromagnetic coupling.
Such iron-sulfur clusters are difficult to analyze by
w xEPR spectroscopy 65 and it therefore remains un-
certain whether both clusters are present and could be
detected by EPR in complex I. At present, it cannot
be excluded that the tetranuclear iron-sulfur cluster
N-2 is located in subunit TYKY, but the structural
similarity of this protein to bacterial low potential
ferredoxins, which carry two tetranuclear clusters in
close vicinity, makes it not a very likely candidate.
PSST does not carry a motif which would identify
this subunit unambiguously as an iron-sulfur protein,
but its amino-acid sequence contains three conserved
possible cysteine-ligands for an iron-sulfur cluster.
Because the third cysteine is immediately followed
by a proline, it has been suggested that this subunit
carries a Fe S -cluster and that the fourth ligand4 4
might be a conserved glutamate three residues down-
w xstream from the first cysteine 38 . Such a cluster
would be expected to have unusual properties, mak-
ing it an interesting candidate for iron-sulfur center
N-2. The impressive number of 40–50 charged
residues in a protein with about 150 amino acids that
can be found in the bacterial and mammalian subunit
fits well into the picture of a subunit carrying a
redox-group involved in proton-translocation. How-
ever, mutagenesis work will be required to answer
the question whether PSST is in fact the N-2 iron-
sulfur protein.
No matter which of the two subunits carries cluster
N-2, both, like cluster N-2 itself, have been assigned
to the peripheral part of the enzyme. While this
includes the possibility that the subunits might be
submerged into the membrane domain to a certain
extent, it certainly means that cluster N-2 is located
more on the negative side of the membrane and has
to play its supposed role in proton-translocation from
there.
Summarizing the discussion up to this point, pre-
sent knowledge on structure and function of complex
I gives only a rather crude picture of this large and
complicated enzyme. Still, there seems to be suffi-
cient information to indicate where one has to look
for the proton-translocating machinery and which
components are likely to contribute to this process.
At this point, FMN cannot be excluded with absolute
certainty as a possible player, but clearly attention
should focus on ubiquinone and iron-sulfur cluster
N-2 as contributors to the proton-translocating ma-
chinery.
Due to the properties of iron-sulfur cluster N-2
described above, this redox-center by itself could
operate as the central part of a proton-translocating
w xdevice 13,50,57,58 , accepting a proton from the
negative side of the membrane upon reduction and
releasing it towards the positive side following reoxi-
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dation. However, as indicated also by the ns1
pH-dependence of the cluster N-2 midpoint potential,
such a mechanism would contribute only 2 Hqr2ey
or 50% of the total proton-translocation capability of
complex I. This means that the same number of
protons would have to be translocated by an un-
known ubiquinone dependent mechanism for which
no supporting redox group is known. Combining a
mechanism involving cluster N-2 as a proton-gate
and the semiquinone mechanism proposed by Vino-
w xgradov 25 would result in a stoichiometry of only 3
Hqr2ey, which is less than the 4 Hqr2ey suggested
by other authors. Moreover, it seems rather arbitrary
to postulate that two adjacent components of com-
plex I would operate as two essentially independent
proton-translocators. The objective then would be to
develop a mechanistic model that is based on the
combined action of cluster N-2 as a redox-Bohr
group and ubiquinone as a hydrogen carrier.
7. Properties of ubiquinone intermediates
At center P of the cytochrome bc complex bifur-1
cated electron flow and thereby vectorial proton-
transfer is also based on the combined action of an
iron-sulfur center and ubiquinone. A proton-gated
charge-transfer mechanism operating at the core of a
w xprotonmotive Q-cycle 36,67 has been proposed re-
cently to describe the chemistry of this interaction
w x48,68 . Despite of the many differences between
complex I and cytochrome bc complex, some of the1
general concepts developed to describe the mecha-
nism of the cytochrome bc complex should provide1
a useful guideline to develop a mechanistic model for
complex I. Most notably, ubiquinone is involved as a
hydrogen carrier in proton-translocation by both res-
piratory chain complexes.
Reexamination of the biophysical properties of the
redox-states of ubiquinone is prerequisite to explore
its suggested role in the proton-translocating mecha-
nism of complex I. The E and pK values of them7 a
ubiquinone intermediates determined in 80% ethanol
are summarized in Fig. 4. Although these parameters
could be significantly different in the bound state,
they provide a useful starting point and it should be
possible to rationalize any deviation by correlating it
with properties of the binding site. Likewise, if a
Fig. 4. Ubiquinone intermediates. E values and pK valuesm a
w x w xwere taken from 66 and 48 .
determined pK or midpoint potential of a ubiquinonea
intermediate differs from the values in solution, this
can give important clues on the environment of the
bound species. A useful rule of thumb for an electro-
static change in the environment of ubiquinone inter-
mediates is that an increase of the midpoint is ex-
pected to lower the pK of the species, and vicea
versa.
Proton-translocation by ligand conduction is estab-
lished by ubihydroquinone oxidation with proton-re-
lease on one side of the membrane and ubiquinone
reduction with proton uptake on the other side of the
membrane. Taking the rather negative potential of the
iron-sulfur clusters of complex I, reduction of
ubiquinone is thermodynamically no problem. Thus,
the crucial question is, whether there is a mechanism
by which ubihydroquinone can be oxidized even in
the absence of a high-potential acceptor. To solve this
problem one has to consider that any redox-reaction
of ubiquinone is a sequence of electron- and proton-
transfers and that the rather positive overall midpoint
potential of the QrQH couple of q70 mV is largely2
due to the high pK values for the deprotonation ofa
 .ubihydroquinone see Fig. 4 . In other words, the
fully deprotonated Q2y is a remarkably strong reduc-
tant with E sy240 mV in 80% ethanol. On them7
other hand, following the rule of thumb given above,
lowering the pK values increases the midpoint po-a
tentials. Therefore, a ubihydroquinone-oxidation site
in the membrane domain of complex I has to be
designed such that deprotonation is facilitated, but
that the deprotonated species generated is still a
strong enough reductant to re-reduce a ubiquinone-in-
termediate on the other side of the membrane.
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8. Redox-gated ligand conduction
The mechanistic model of redox-gated ligand-con-
duction shown in Fig. 5 is an attempt to account for
all thermodynamic constraints and experimental evi-
dence available for complex I. In this mechanism a
net stoichiometry of 4 Hqr2ey is realized exclu-
sively by redox-linked protonations and deprotona-
tions of ubiquinone.
 .Three ubiquinone-binding sites see Fig. 5 are
involved in the proposed reaction sequence, namely
one ubihydroquinone oxidation site called center PI
and two ubiquinone reduction sites called center NA
and N . The only iron-sulfur center directly involvedB
is cluster N-2. The other iron-sulfur centers as well as
FMN serve as electron input pathway and may pro-
vide an isopotential pool of reduction equivalents.
 .Upon reduction of cluster N-2 Fig. 5, step 1 its pKa
increases and it abstracts a proton from ubihydro-
quinone bound at center P through a proton channel.I
When N-2 donates electrons to ubiquinone bound at
 .center N Fig. 5, step 2 , it is reoxidized and theA
lowered pK of the associated redox-Bohr groupa
forces a proton out towards the positive side of the
membrane. This step could be promoted by the prop-
Fig. 5. Redox-gated ligand-conduction mechanism. The path of
electrons from the low potential iron-sulfur centers of the periph-
eral part to ubiquinone is described as a series of numbered
reactions shown by solid arrows. Reactions 1 to 3 have to occur
twice for a complete reaction sequence. White numbers on black
circles indicate proton-movements associated with the respective
electron-transfer reaction marked with black numbers on white
circles. Thick open arrows indicate proton movement, uptake or
release. See text for further details. N , center N ; N , centerA A B
N ; P , center P . See also legend of Fig. 1.B I I
erties of the proton channel necessary for this proton
extrusion.
Center P is proposed to lower the pK of theI a
bound ubihydroquinone to some extent. This would
allow one spontaneous deprotonation and the abstrac-
tion of the second proton by the reduced cluster N-2
even if its pK is not very high, and would lead toa
the generation of Q2y. Q2y is still at a potential
negative enough to reduce the semiquinone formed at
 . center N step 2 to ubihydroquinone Fig. 5, stepA
.3 . This results in the uptake of two protons on the
negative side of the membrane..
The semiquinone formed at center P then reducesI
ubiquinone bound at center N to form ubisemi-B
 .quinone Fig. 5, step 4a . Subsequently the whole
sequence is repeated with the exception that now the
ubisemiquinone bound at center N is completelyB
 .reduced to ubihydroquinone Fig. 5, step 4b leading
to the uptake of another two protons from the nega-
tive side of the membrane.
A complete reaction sequence leads to the oxida-
tion of 1 NADH and the net reduction of 1 ubiquinone.
2 protons are released and 6 taken up on the negative
side, while 4 protons are released on the positive
side.
Note, that if the ubiquinone binding sites are close
enough to each other no electron transferring redox
groups are required for this reaction.
The essential feature of this model of proton-trans-
location by complex I is the linkage between reduc-
tion of cluster N-2 and deprotonation of ubihydro-
quinone at center P . By coupling these two reactionsI
the potential drop between the iron-sulfur cluster and
a stabilized QrQPy couple can be used to drive
oxidation of ubihydroquinone on the other side of the
membrane. To have the system operate efficiently
one has to propose that the redox-Bohr group associ-
ated with cluster N-2 is linked to the ‘input’-channel,
when the iron-sulfur center is reduced and to the
‘output’-channel when it is oxidized. Certainly, the
‘timing’ of the individual proton- and electron-trans-
fer steps is critical for efficient proton-translocation
and it is quite likely that the redox-gated ligand-con-
duction mechanism would tend to ‘slip’. In fact,
variable proton-translocation stoichiometries have
been observed with complex I under certain condi-
w xtions 5,39 . It is also tempting to speculate that the
pH- and cation-dependent transition between active
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w xand deactivated forms of complex I 25,69 might be
related to the redox-Bohr group getting trapped in an
inactive state. If indeed a transmembrane proton-
channel leading from center P to cluster N-2 exists,I
an interesting side effect would be that the deprotona-
tion of ubihydroquinone bound to the ubihydro-
quinone-oxidation site would actually be promoted
by the membrane potential. This could ensure effi-
cient proton-translocation in the energized state due
to a decrease of the effective midpoint potential of
the ubisemiquinone bound to center P . Note that inI
this case the steady-state reaction would still be
inhibited by the membrane potential as deprotonation
of iron-sulfur cluster N-2 is predicted to be highly
electrogenic.
Although the presentation of the redox-gated lig-
and-conduction mechanism in Fig. 5 is presented in a
way suggesting that all ubiquinones are freely ex-
changeable with the ubiquinone-pool, this is not a
necessary implication of the model. The same mecha-
nism could operate based on the assumption of some
sort of substrate channeling between the ubiquinone
binding sites as suggested by some experimental
w xreports 70,71 .
It should also be stressed that the model shown in
Fig. 5 is only one of several possible mechanisms
that can be proposed using the same general con-
cepts. For example, if the second ubiquinone-reduc-
 .tion site N was omitted and both electrons fromB
the ubihydroquinone-oxidation site were transferred
to the same ubiquinone reduction site, this would
result in a reaction scheme translocating only 2
Hqr2ey. In this case cluster N-2 could assist in the
abstraction of both protons from ubihydroquinone,
but a second proton-translocating device within com-
plex I would be needed to account for the overall
stoichiometry of 4 Hqr2ey.
9. Ubiquinone and inhibitor binding-sites
To test and refine the hypothesis of a redox-gated
ligand conduction mechanism it will be essential to
determine the number and properties of ubiquinone
binding-sites of complex I. As discussed above, there
are several lines of evidence indicating that there are
at least two ubiquinone binding sites.
Within the redox-gated ligand-conduction mecha-
nism the two types of semiquinone bound to complex
w xI detected by EPR spectroscopy 29 should be asso-
ciated with centers N and N , as the ubisemi-A B
quinone at center P should be the least stable.I
The impressive array of different hydrophobic in-
hibitors of complex I most of which are likely to be
w xubiquinone-analogs 26,72–75 can be grouped into
different classes based on a number of kinetic studies.
Friedrich et al. have defined two classes of inhibitors
based on Michaelis-Menten type inhibition kinetics
with complex I from three different organisms and a
comparison with inhibition of glucose dehydrogenase
from Gluconobacter oxidans by the same set of 12
w xinhibitors 76 . Class I inhibitors, represented by pie-
ricidin A, inhibit complex I in a partially competitive
manner and also inhibit glucose dehydrogenase com-
petitively. Class II inhibitors, represented by rotenone,
inhibit complex I in a non-competitive manner, and
glucose dehydrogenase is not inhibited at all. Degli
w xEsposti et al. have found 77 that stigmatellin and
myxothiazol, which are known as very tight binding
w xinhibitors of the cytochrome bc complex 78 , in-1
hibit complex I at micromolar concentration without
competing with piericidin A or rotenone. With some
caveats, this can be taken as an indication for a third
ubiquinone binding site of complex I. A more de-
tailed discussion of the large body of literature on the
action of different inhibitors of complex I would be
beyond the scope of this review. However, if indeed
there are three classes of inhibitors of complex I, in
terms of the redox-gated ligand-conduction mecha-
nism, a tentative assignment would be that piericidin
inhibits center N , rotenone inhibits center P andA I
myxothiazolrstigmatellin inhibit center N .B
10. Conclusions
Although knowledge about structure and function
of complex I is still rather limited when compared to
other respiratory chain complexes, based on the evi-
dence available the contours of the proton-translocat-
ing mechanism operating in this complicated multi-
subunit enzyme seem to emerge. The hypothesis of a
redox-gated ligand conduction mechanism proposed
here describes proton-translocation by complex I as a
series of defined chemical reactions. It makes specific
predictions on the role of iron-sulfur cluster and the
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properties of the three postulated ubiquinone binding
sites. This should make the model easily testable and
hopefully stimulate further experimental work. It will
be of particular importance to find a way to test
whether in fact ubihydroquinone is oxidized by a
partial reaction of complex I and whether this reac-
tion is linked to a redox-dependent protonation of
iron-sulfur cluster N-2.
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